ArticleEmerging infectious diseases2006
Universal genotyping in tuberculosis control program, New York City, 2001-2003.
Article in Emerging infectious diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Molecular epidemiology of tuberculosis after declining incidence, New York City, 2001-2003.Epidemiology and infection · 2007Trial
- Genotyped cluster investigations versus standard contact tracing: comparative impact on latent tuberculosis infection cascade of care in a low-incidence region.BMC infectious diseases · 2025Article
- Molecular typing of Mycobacterium tuberculosis: a review of current methods, databases, softwares, and analytical tools.FEMS microbiology reviews · 2025Review
- Spatiotemporal patterns and ecological factors of tuberculosis notification: A spatial panel data analysis in Guangxi, China.PloS one · 2019Article
- Universal Genotyping for Tuberculosis Prevention Programs: a 5-Year Comparison with On-Request Genotyping.Journal of clinical microbiology · 2018Article
- Recent transmission of Mycobacterium tuberculosis in China: the implication of molecular epidemiology for tuberculosis control.Frontiers of medicine · 2018Review
- Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis.The Lancet. Public health · 2017Article
- Exploring genotype concordance in epidemiologically linked cases of tuberculosis in New York City.Epidemiology and infection · 2017Article
- High Tuberculosis Strain Diversity Among New York City Public Housing Residents.American journal of public health · 2016Article
- Risk for Tuberculosis Disease Among Contacts with Prior Positive Tuberculin Skin Test: A retrospective Cohort Study, New York City.Journal of general internal medicine · 2015Article
- Disparities in tuberculosis burden among South Asians living in New York City, 2001-2010.American journal of public health · 2015Article
- Prospective evaluation of a complex public health intervention: lessons from an initial and follow-up cross-sectional survey of the tuberculosis strain typing service in England.BMC public health · 2014Article
- Correlations between major risk factors and closely related Mycobacterium tuberculosis isolates grouped by three current genotyping procedures: a population-based study in northeast Mexico.Memorias do Instituto Oswaldo Cruz · 2014Article
- Molecular epidemiology of Mycobacterium tuberculosis in the United States-Affiliated Pacific Islands.Asia-Pacific journal of public health · 2014Article
- Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RD(Rio) Mycobacterium tuberculosis sublineage.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2012Article
- Epidemiologic consequences of microvariation in Mycobacterium tuberculosis.The Journal of infectious diseases · 2012Article
- Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States.Emerging infectious diseases · 2012Article
- Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009.Emerging infectious diseases · 2011Article
- Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry.Journal of clinical microbiology · 2011Article
- Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies.Future microbiology · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2001, New York City implemented genotyping to its tuberculosis (TB) control activities by using IS6110 restriction fragment length polymorphism (RFLP) and spoligotyping to type isolates from culture-positive TB patients. Results are used to identify previously unknown links among genotypically clustered patients, unidentified sites of transmission, and potential false-positive cultures. From 2001 to 2003, spoligotype and IS6110-based RFLP results were obtained for 90.7% of eligible and 93.7% of submitted isolates. Fifty-nine (2.4%) of 2,437 patient isolates had false-positive culture results, and 205 genotype clusters were identified, with 2-81 cases per cluster. Cluster investigations yielded 57 additional links and 17 additional sites of transmission. Four additional TB cases were identified as a result of case finding initiated through cluster investigations. Length of unnecessary treatment decreased among patients with false-positive cultures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.